Protagonist Therapeutics, Inc Deferred Tax Assets, Operating Loss Carryforwards
Protagonist Therapeutics, Inc (PTGX) had Deferred Tax Assets, Operating Loss Carryforwards of $54.05 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $54.05M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $8.88M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $70.47M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $76.13M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $54.05M 10-K · filed 2026-02-25 |
| 2024-12-31 | $8.88M 10-K · filed 2026-02-25 |
| 2023-12-31 | $70.47M 10-K · filed 2025-02-21 |
| 2022-12-31 | $76.13M 10-K · filed 2024-02-27 |
| 2021-12-31 | $75.65M 10-K · filed 2023-03-15 |
| 2020-12-31 | $50.27M 10-K · filed 2022-02-28 |
| 2019-12-31 | $39.91M 10-K · filed 2021-03-10 |
| 2018-12-31 | $27.70M 10-K · filed 2020-03-10 |
| 2017-12-31 | $21.68M 10-K · filed 2019-03-12 |
| 2016-12-31 | $21.50M 10-K · filed 2018-03-07 |
| 2015-12-31 | $9.51M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |